MIRA Pharmaceuticals News

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Aminov Erez

Nov 27 16:18 ET

MIRA Pharmaceuticals | 3: Initial statement of beneficial ownership of securities-Director Whalen Matthew Pratt

Nov 26 16:19 ET

MIRA Pharmaceuticals | 8-K: Current report

Nov 21 16:22 ET

MIRA Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Nov 19 18:01 ET

MIRA Pharmaceuticals | 8-K: Current report

Nov 19 16:12 ET

MIRA Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12 16:50 ET

MIRA Pharmaceuticals | 8-K: Current report

Oct 25 16:03 ET

MIRA Pharmaceuticals | 8-K: Current report

Oct 21 07:04 ET

MIRA Pharmaceuticals | 424B5: Prospectus

Sep 27 17:24 ET

MIRA Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Sep 27 16:49 ET

MIRA Pharmaceuticals | 8-K: Current report

Sep 12 16:34 ET

MIRA Pharmaceuticals | 8-K: Current report

Sep 10 16:04 ET

MIRA Pharmaceuticals | 144/A: Others

Sep 6 16:40 ET

MIRA Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 4 20:26 ET

MIRA Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-10% Owner McNulty Brian Patrick

Aug 30 16:10 ET

MIRA Pharmaceuticals | 8-K: Current report

Aug 23 16:17 ET

MIRA Pharmaceuticals | EFFECT: Others

Aug 19 06:03 ET

MIRA Pharmaceuticals | 10-Q/A: Quarterly report (Amendment)

Aug 16 16:08 ET

MIRA Pharmaceuticals | CORRESP: CORRESP

Aug 15 22:31 ET

MIRA Pharmaceuticals | UPLOAD: Others

Aug 15 22:30 ET